Inhibition of epidermal growth factor receptor tyrosine kinase ameliorates collagen-induced arthritis

Journal of Immunology

Volumn 188, Issue 7, 2012, Pages 3513-3521

  Swanson, Christina D ^a,b   Akama Garren, Elliot H ^a   Stein, Emily A ^a,b   Petralia, Jacob D ^a   Ruiz, Pedro J ^a   Edalati, Abdolhossein ^b   Lindstrom, Tamsin M ^a,b   Robinson, William H ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; ERLOTINIB; GELATINASE B; INTERLEUKIN 8; LACTATE DEHYDROGENASE; MATRIX METALLOPROTEINASE 14; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN FOS; PROTEIN KINASE B; STROMELYSIN; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CARTILAGE DEGENERATION; CARTILAGE EROSION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE COMPARISON; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME INHIBITION; FIBROBLAST; HUMAN; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; PANNUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SYNOVITIS; SYNOVIUM;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CELL DIVISION; CYCLOOXYGENASE 2; CYTOKINES; DRUG EVALUATION, PRECLINICAL; ENDOTHELIAL CELLS; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MALE; MICE; MICE, INBRED DBA; NEOVASCULARIZATION, PATHOLOGIC; OSTEOCLASTS; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-SIS; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; SYNOVIAL MEMBRANE;

EID: 84859412485     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102693     Document Type: Article

References (46)

1. Cope, A. P. 2008. T cells in rheumatoid arthritis. Arthritis Res. Ther. 10(Suppl. 1): S1.
2. Scott, D. L., F. Wolfe, and T. W. Huizinga. 2010. Rheumatoid arthritis. Lancet 376: 1094-1108.
3. Firestein, G. S. 1999. Starving the synovium: angiogenesis and inflammation in rheumatoid arthritis. J. Clin. Invest. 103: 3-4. (Pubitemid 29031156)
4. Schett, G. 2007. Cells of the synovium in rheumatoid arthritis: osteoclasts. Arthritis Res. Ther. 9: 203.
5. Sullivan, T., C. G. Benjamin, P. W. Kempf, and J. F. Deeken. 2010. Cetuximab in the treatment of rheumatoid arthritis. J. Clin. Rheumatol. 16: 32-33.
6. Sumariwalla, P. F., P. Jin, J. Zhang, I. Ni, D. Crawford, H. M. Shepard, E. M. Paleolog, and M. Feldmann. 2008. Antagonism of the human epidermal growth factor receptor family controls disease severity in murine collagen-induced arthritis. Arthritis Rheum. 58: 3071-3080.
7. Gompels, L. L., N. M. Malik, L. Madden, P. Jin, M. Feldmann, H. M. Shepard, and E. M. Paleolog. 2011. Human epidermal growth factor receptor bispecific ligand trap RB200: abrogation of collagen-induced arthritis in combination with tumour necrosis factor blockade. Arthritis Res. Ther. 13: R161.
8. Herbst, R. S. 2004. Review of epidermal growth factor receptor biology. Int. J. Radiat. Oncol. Biol. Phys. 59(2, Suppl)21-26. (Pubitemid 38610223)
9. Yamane, S., S. Ishida, Y. Hanamoto, K. Kumagai, R. Masuda, K. Tanaka, N. Shiobara, N. Yamane, T. Mori, T. Juji, et al. 2008. Proinflammatory role of amphiregulin, an epidermal growth factor family member whose expression is augmented in rheumatoid arthritis patients. J. Inflamm. (Lond.) 5: 5.
10. Young, C. L., T. C. Adamson, III, J. H. Vaughan, and R. I. Fox. 1984. Immunohistologic characterization of synovial membrane lymphocytes in rheumatoid arthritis. Arthritis Rheum. 27: 32-39. (Pubitemid 14176534)
11. Farahat, M. N., G. Yanni, R. Poston, and G. S. Panayi. 1993. Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis. Ann. Rheum. Dis. 52: 870-875. (Pubitemid 24019143)
12. Kusada, J., T. Otsuka, N. Matsui, T. Hirano, K. Asai, and T. Kato. 1993. Immuno-reactive human epidermal growth factor (h-EGF) in rheumatoid synovial fluids. Nippon Seikeigeka Gakkai Zasshi 67: 859-865. (Pubitemid 23317791)
13. Lu, J. F., S. M. Eppler, J. Wolf, M. Hamilton, A. Rakhit, R. Bruno, and B. L. Lum. 2006. Clinical pharmacokinetics of erlotinib in patients with solid tumors and exposure-safety relationship in patients with non-small cell lung cancer. Clin. Pharmacol. Ther. 80: 136-145. (Pubitemid 44160689)
14. Paniagua, R. T., O. Sharpe, P. P. Ho, S. M. Chan, A. Chang, J. P. Higgins, B. H. Tomooka, F. M. Thomas, J. J. Song, S. B. Goodman, et al. 2006. Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis. J. Clin. Invest. 116: 2633-2642. (Pubitemid 44511627)
15. Higgins, B., K. Kolinsky, M. Smith, G. Beck, M. Rashed, V. Adames, M. Linn, E. Wheeldon, L. Gand, H. Birnboeck, and G. Hoffmann. 2004. Antitumor activity of erlotinib (OSI-774, Tarceva) alone or in combination in human non-small cell lung cancer tumor xenograft models. Anticancer Drugs 15: 503-512. (Pubitemid 38736950)
16. Hidalgo, M., and D. Bloedow. 2003. Pharmacokinetics and pharmacodynamics: maximizing the clinical potential of Erlotinib (Tarceva). Semin. Oncol. 30(3, Suppl. 7)25-33. (Pubitemid 36828625)
17. Abeles, A. M., and M. H. Pillinger. 2006. The role of the synovial fibroblast in rheumatoid arthritis: cartilage destruction and the regulation of matrix metalloproteinases. Bull. NYU Hosp. Jt. Dis. 64: 20-24. (Pubitemid 44625529)
18. Goddard, D. H., S. L. Grossman, and M. E. Moore. 1990. Autocrine regulation of rheumatoid arthritis synovial cell growth in vitro. Cytokine 2: 149-155.
19. Huber, L. C., P. Künzler, S. H. Boyce, B. A. Michel, R. E. Gay, B. S. Ink, and S. Gay. 2008. Effects of a novel tyrosine kinase inhibitor in rheumatoid arthritis synovial fibroblasts. Ann. Rheum. Dis. 67: 389-394. (Pubitemid 351281276)
20. Taylor, D. J., M. Feldmann, J. M. Evanson, and D. E. Woolley. 1989. Comparative and combined effects of transforming growth factors α and α, interleukin-1 and interferon-gamma on rheumatoid synovial cell proliferation, glycolysis and prostaglandin E production. Rheumatol. Int. 9: 65-70. (Pubitemid 19218868)
21. 2 production via ERK1/2 MAPK and NF-κB pathway in fibroblast like synoviocytes from patients with rheumatoid arthritis. Rheumatol. Int. 30: 443-449.
22. Maruotti, N., F. P. Cantatore, E. Crivellato, A. Vacca, and D. Ribatti. 2006. Angiogenesis in rheumatoid arthritis. Histol. Histopathol. 21: 557-566.
23. Endo, H., T. Akahoshi, K. Takagishi, S. Kashiwazaki, and K. Matsushima. 1991. Elevation of interleukin-8 (IL-8) levels in joint fluids of patients with rheumatoid arthritis and the induction by IL-8 of leukocyte infiltration and synovitis in rabbit joints. Lymphokine Cytokine Res. 10: 245-252.
24. Ogata, H., M. Takeya, T. Yoshimura, K. Takagi, and K. Takahashi. 1997. The role of monocyte chemoattractant protein-1 (MCP-1) in the pathogenesis of collagen-induced arthritis in rats. J. Pathol. 182: 106-114. (Pubitemid 27240456)
25. Ainola, M. M., J. A. Mandelin, M. P. Liljeström, T. F. Li, M. V. Hukkanen, and Y. T. Konttinen. 2005. Pannus invasion and cartilage degradation in rheumatoid arthritis: involvement of MMP-3 and interleukin-1b. Clin. Exp. Rheumatol. 23: 644-650. (Pubitemid 41300706)
26. FitzGerald, O., M. Soden, G. Yanni, R. Robinson, and B. Bresnihan. 1991. Morphometric analysis of blood vessels in synovial membranes obtained from clinically affected and unaffected knee joints of patients with rheumatoid arthritis. Ann. Rheum. Dis. 50: 792-796.
27. Wu, L. W., L. D. Mayo, J. D. Dunbar, K. M. Kessler, M. R. Baerwald, E. A. Jaffe, D. Wang, R. S. Warren, and D. B. Donner. 2000. Utilization of distinct signaling pathways by receptors for vascular endothelial cell growth factor and other mitogens in the induction of endothelial cell proliferation. J. Biol. Chem. 275: 5096-5103. (Pubitemid 30108910)
28. Mehta, V. B., and G. E. Besner. 2007. HB-EGF promotes angiogenesis in endothelial cells via PI3-kinase and MAPK signaling pathways. Growth Factors 25: 253-263.
29. Mehta, V. B., Y. Zhou, A. Radulescu, and G. E. Besner. 2008. HB-EGF stimulates eNOS expression and nitric oxide production and promotes eNOS dependent angiogenesis. Growth Factors 26: 301-315. (Pubitemid 352781843)
30. Semino, C. E., R. D. Kamm, and D. A. Lauffenburger. 2006. Autocrine EGF receptor activation mediates endothelial cell migration and vascular morphogenesis induced by VEGF under interstitial flow. Exp. Cell Res. 312: 289-298. (Pubitemid 41814838)
31. Baraf, H. S. 2007. Efficacy of the newest COX-2 selective inhibitors in rheumatic disease. Curr. Pharm. Des. 13: 2228-2236. (Pubitemid 47317032)
32. Siegle, I., T. Klein, J. T. Backman, J. G. Saal, R. M. Nüsing, and P. Fritz. 1998. Expression of cyclooxygenase 1 and cyclooxygenase 2 in human synovial tissue: differential elevation of cyclooxygenase 2 in inflammatory joint diseases. Arthritis Rheum. 41: 122-129. (Pubitemid 28041930)
33. Woods, J. M., A. Mogollon, M. A. Amin, R. J. Martinez, and A. E. Koch. 2003. The role of COX-2 in angiogenesis and rheumatoid arthritis. Exp. Mol. Pathol. 74: 282-290. (Pubitemid 36629226)
34. Choi, Y., J. R. Arron, and M. J. Townsend. 2009. Promising bone-related therapeutic targets for rheumatoid arthritis. Nat Rev Rheumatol 5: 543-548.
35. Choi, S., Y. A. Lee, S. J. Hong, G. J. Lee, S. W. Kang, J. H. Park, and H. K. Park. 2011. Evaluation of inflammatory change and bone erosion using a murine type II collagen-induced arthritis model. Rheumatol. Int. 31: 595-603.
36. Rho, J., C. R. Altmann, N. D. Socci, L. Merkov, N. Kim, H. So, O. Lee, M. Takami, A. H. Brivanlou, and Y. Choi. 2002. Gene expression profiling of osteoclast differentiation by combined suppression subtractive hybridization (SSH) and cDNA microarray analysis. DNA Cell Biol. 21: 541-549.
37. Boyce, B. F., T. Yamashita, Z. Yao, Q. Zhang, F. Li, and L. Xing. 2005. Roles for NF-κB and c-Fos in osteoclasts. J. Bone Miner. Metab. 23(Suppl.): 11-15.
38. Yi, T., H. L. Lee, J. H. Cha, S. I. Ko, H. J. Kim, H. I. Shin, K. M. Woo, H. M. Ryoo, G. S. Kim, and J. H. Baek. 2008. Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling. J. Cell. Physiol. 217: 409-422.
39. Leaman, D. W., S. Pisharody, T. W. Flickinger, M. A. Commane, J. Schlessinger, I. M. Kerr, D. E. Levy, and G. R. Stark. 1996. Roles of JAKs in activation of STATs and stimulation of c-fos gene expression by epidermal growth factor. Mol. Cell. Biol. 16: 369-375. (Pubitemid 126506983)
40. Nakamura, N., Y. Shimaoka, T. Tougan, H. Onda, D. Okuzaki, H. Zhao, A. Fujimori, N. Yabuta, I. Nagamori, A. Tanigawa, et al. 2006. Isolation and expression profiling of genes upregulated in bone marrow-derived mononuclear cells of rheumatoid arthritis patients. DNA Res. 13: 169-183. (Pubitemid 44726367)
41. Hallbeck, A. L., T. M. Walz, K. Briheim, and A. Wasteson. 2005. TGF-α and ErbB2 production in synovial joint tissue: increased expression in arthritic joints. Scand. J. Rheumatol. 34: 204-211. (Pubitemid 40978641)
42. Kim, H. S., H. S. Shin, H. J. Kwak, C. H. Cho, C. O. Lee, and G. Y. Koh. 2003. Betacellulin induces angiogenesis through activation of mitogen-activated protein kinase and phosphatidylinositol 39-kinase in endothelial cell. FASEB J. 17: 318-320.
43. Wang, K., H. Yamamoto, J. R. Chin, Z. Werb, and T. H. Vu. 2004. Epidermal growth factor receptor-deficient mice have delayed primary endochondral ossification because of defective osteoclast recruitment. J. Biol. Chem. 279: 53848-53856. (Pubitemid 40051894)
44. Raza, K., F. Falciani, S. J. Curnow, E. J. Ross, C. Y. Lee, A. N. Akbar, J. M. Lord, C. Gordon, C. D. Buckley, and M. Salmon. 2005. Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res. Ther. 7: R784-R795.
45. Fabre, S., A. M. Dupuy, N. Dossat, C. Guisset, J. D. Cohen, J. P. Cristol, J. P. Daures, and C. Jorgensen. 2008. Protein biochip array technology for cytokine profiling predicts etanercept responsiveness in rheumatoid arthritis. Clin. Exp. Immunol. 153: 188-195. (Pubitemid 351989164)
46. Gazdar, A. F. 2010. Epidermal growth factor receptor inhibition in lung cancer: the evolving role of individualized therapy. Cancer Metastasis Rev. 29: 37-48.